共 18 条
[1]
[2]
Allogeneic Bone Marrow–Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn’s Disease[J] Ilse Molendijk;Bert A. Bonsing;Helene Roelofs;Koen C.M.J. Peeters;Martin N.J.M. Wasser;Gerard Dijkstra;C. Janneke van der Woude;Marjolijn Duijvestein;Roeland A. Veenendaal;Jaap-Jan Zwaginga;Hein W. Verspaget;Willem E. Fibbe;Andrea E. van der Meulen-de Jong;Daniel W. Hommes Gastroenterology 2015,
[3]
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial[J] Reena Khanna;Brian Bressler;Barrett G Levesque;Guangyong Zou;Larry W Stitt;Gordon R Greenberg;Remo Panaccione;Alain Bitton;Pierre Paré;Séverine Vermeire;Geert D'Haens;Donald MacIntosh;William J Sandborn;Allan Donner;Margaret K Vandervoort;Joan C Morris;Brian G Feagan The Lancet 2015,
[4]
Randomised clinical trial: deep remission in biologic and immunomodulator na?ve patients with Crohn's disease – a SONIC post hoc analysis[J] J.‐F. Colombel;W. Reinisch;G. J. Mantzaris;A. Kornbluth;P. Rutgeerts;K. L. Tang;A. Oortwijn;G. S. Bevelander;F. J. Cornillie;W. J. Sandborn Aliment Pharmacol Ther 2015,
[5]
Withdrawal of Immunomodulators After Co-treatment Does Not Reduce Trough Level of Infliximab in Patients With Crohn’s Disease[J] David Drobne;Peter Bossuyt;Christine Breynaert;Tom Cattaert;Niels Vande Casteele;Griet Compernolle;Matthias Jürgens;Marc Ferrante;Vera Ballet;Willem-Jan Wollants;Isabelle Cleynen;Kristel Van Steen;Ann Gils;Paul Rutgeerts;Severine Vermeire;Gert Van Assche Clinical Gastroenterology and Hepatology 2015,
[6]
Low‐dose azathioprine effectively improves mucosal healing in C hinese patients with small bowel C rohn's disease[J] Li Fen Yu;Jie Zhong;Shi Dan Cheng;Yong Hua Tang;Fei Miao Journal of Digestive Diseases 2014,
[7]
Remission of refractory C rohn's disease by high‐dose cyclophosphamide and autologous peripheral blood stem cell transplantation[J] P. Hasselblatt;K. Drognitz;K. Potthoff;H. Bertz;W. Kruis;C. Schmidt;A. Stallmach;A. Schmitt‐Graeff;J. Finke;W. Kreisel Aliment Pharmacol Ther 2012,
[8]
Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial[J] Paul Rutgeerts;Gert Van Assche;William J. Sandborn;Douglas C. Wolf;Karel Geboes;Jean–Frédéric Colombel;Walter Reinisch;Ashish Kumar;Andreas Lazar;Anne Camez;Kathleen G. Lomax;Paul F. Pollack;Geert D'Haens Gastroenterology 2012,
[9]
Reinduction With Certolizumab Pegol in Patients With Relapsed Crohn's Disease: Results From the PRECiSE 4 Study[J] William J. Sandborn;Stefan Schreiber;Stephen B. Hanauer;Jean–Frédéric Colombel;Ralph Bloomfield;Gary R. Lichtenstein Clinical Gastroenterology and Hepatology 2010,
[10]
Continuous Therapy With Certolizumab Pegol Maintains Remission of Patients With Crohn's Disease for up to 18 Months[J] Clinical Gastroenterology and Hepatology 2010,